{"url_path":"/sec/fbrx/8-k/2026-05-14/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1419041/0001193125-26-224214-index.html","accession_number":"0001193125-26-224214","cik":"0001419041","ticker":"FBRX","issuer_name":"Forte Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1419041/0001193125-26-224214-index.html","primary_entity_key":"0001419041","primary_entity_name":"Forte Biosciences, Inc."},"word_count":76,"has_tables":true,"body_markdown":"Item 9.01. Financial Statements and Exhibits.\n\n(d) Exhibits\n\n \n\nExhibit\n  \n\nDescription\n\n99.1\n  \n[Press Release dated May 11, 2026](d95486dex991.htm)\n\n104\n  \nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \nFORTE BIOSCIENCES, INC.\n\nDate: May 14, 2026\n \n\n \nBy:\n \n\n/s/ Antony Riley\n\n \n\n \n\n \n\nAntony Riley\n\nChief Financial Officer"}